Scientific Industries Inc (SCND) — SEC Filings
Scientific Industries Inc (SCND) — 34 SEC filings. Latest: DEF 14A (Dec 29, 2025). Includes 10 8-K, 6 10-Q, 6 S-1/A.
View Scientific Industries Inc on SEC EDGAR
Overview
Scientific Industries Inc (SCND) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEF 14A filed on Dec 29, 2025: SCIENTIFIC INDUSTRIES INC (SCND) is holding its 2024 Annual Meeting of Shareholders on January 22, 2026, virtually. Key proposals include the re-election of two Class A Directors, Helena Santos and Jurgen Schumacher, to serve until the 2027 annual meeting. The company also seeks approval to amend it
Sentiment Summary
Across 34 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 28 neutral, 3 mixed. The dominant filing sentiment for Scientific Industries Inc is neutral.
Filing Type Overview
Scientific Industries Inc (SCND) has filed 1 DEF 14A, 1 8-K/A, 6 10-Q, 10 8-K, 6 S-1/A, 2 10-K, 4 SC 13G/A, 1 SC 13D/A, 1 10-K/A, 1 S-1, 1 SC 13G with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (34)
Risk Profile
Risk Assessment: Of SCND's 28 recent filings, 1 were flagged as high-risk, 16 as medium-risk, and 11 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $3,427,100 |
| Net Income | $692,200 |
| EPS | N/A |
| Debt-to-Equity | 0.17 |
| Cash Position | $1,162,600 |
| Operating Margin | N/A |
| Total Assets | $14,557,400 |
| Total Debt | $2,095,700 |
Key Executives
- Helena Santos
- Jurgen Schumacher
- John A. Moore
- Brian Pessin
- Michael Blechman
- John F.F. Watkins, Esq.
- David M. Scholl
- Dr. Jonathan S. Roth
- John F.F. Watkins
- Dr. Daniel J. Levitt
- Dr. James P. Muldoon
- Dr. James P. O'Brien
Industry Context
Scientific Industries Inc. operates in the scientific equipment and laboratory instrumentation sector. This industry is characterized by innovation, demand for precision, and a need for reliable performance in research and development settings. Key trends include automation, miniaturization, and the integration of digital technologies into laboratory workflows.
Top Tags
Laboratory Instruments (5) · amendment (4) · financials (4) · S-1/A (4) · SEC Filing (4) · Scientific Industries (4) · earnings (3) · 10-Q (3) · Capital Raise (3) · Smaller Reporting Company (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Increase in shares for 2022 Equity Incentive Plan | 3,750,000 shares | Represents potential dilution for existing shareholders |
| Common Stock outstanding | 11,928,599 shares | As of December 16, 2025, the record date |
| Beneficial ownership by Bleichroeder LP | 20.58 % | Largest known beneficial owner |
| Beneficial ownership by Brian Pessin | 16.12 % | Significant beneficial owner |
| Board meetings held | 6 | During the fiscal year ended December 31, 2024 |
| Date of 2024 Annual Meeting | January 22, 2026 | Key date for shareholder decisions |
| Record date for voting | December 16, 2025 | Determines shareholders eligible to vote at the Annual Meeting |
| Term end for Class A Directors | 2027 | Helena Santos and Jurgen Schumacher, if re-elected |
| Net Income | $692,200 | For the nine months ended September 30, 2025, a significant turnaround from a $4,515,400 net loss in the prior year. |
| Gain on disposition of Genie Product Line | $5,263,400 | Major contributor to net income for the nine months ended September 30, 2025. |
| Cash and cash equivalents | $1,162,600 | As of September 30, 2025, more than double from $587,900 at December 31, 2024. |
| Investment securities | $7,131,100 | As of September 30, 2025, a substantial increase from $1,985,000 at December 31, 2024. |
| Proceeds from gain on sale of Genie Product Line | $7,614,200 | Cash inflow from investing activities for the nine months ended September 30, 2025. |
| Revenues from continuing operations | $3,427,100 | For the nine months ended September 30, 2025, a slight decrease from $3,514,600 in the prior year. |
| Accumulated deficit | $33,238,300 | As of September 30, 2025, indicating historical losses despite recent net income. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Scientific Industries Inc (SCND)?
Scientific Industries Inc has 34 recent SEC filings from Jan 2024 to Dec 2025, including 10 8-K, 6 10-Q, 6 S-1/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SCND filings?
Across 34 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 28 neutral, 3 mixed. The dominant sentiment is neutral.
Where can I find Scientific Industries Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Scientific Industries Inc (SCND) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Scientific Industries Inc?
Key financial highlights from Scientific Industries Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SCND?
The investment thesis for SCND includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Scientific Industries Inc?
Key executives identified across Scientific Industries Inc's filings include Helena Santos, Jurgen Schumacher, John A. Moore, Brian Pessin, Michael Blechman and 7 others.
What are the main risk factors for Scientific Industries Inc stock?
Of SCND's 28 assessed filings, 1 were flagged high-risk, 16 medium-risk, and 11 low-risk.
What are recent predictions and forward guidance from Scientific Industries Inc?
Forward guidance and predictions for Scientific Industries Inc are extracted from SEC filings as they are enriched.